The recommendations surround important updates to standard criteria that are commonly used despite being decades old.

Two structurally modified compounds derived from an anti-inflammatory metabolite demonstrated enhanced anti-inflammatory ...

Crohn’s and Colitis Canada’s Grants-in-Aid of Research Program supports investigator-driven research with defined objectives that advance understanding of Crohn’s disease, ulcerative colitis and ...

Montai has dosed the first participants in a Phase 1 trial of MTAI-1025, a novel oral NRF2 agonist for the treatment of ulcerative colitis.

Palisade Bio (NASDAQ:PALI) said it is advancing its lead drug candidate, PALI-2108, into Phase II studies for ulcerative ...

Oral presentation to highlight early endoscopic improvement and evidence of PDE4 target engagement in fibrostenotic Crohn’s disease Three moderated posters to showcase gut-targeted exposure, favorable ...

USA: In the phase IIb RELIEVE UCCD trial, investigational duvakitug improved clinical remission rates in patients with ulcerative colitis and endoscopic response rates in those with Crohn’s disease.

Patients with IBD face a heightened risk for psychiatric disorders that begins years before their IBD is diagnosed and persists for at least a decade.

(d3sign/Moment RF/Getty Images) Some of the healthiest plant-based foods on the menu – including spinach, beetroot, rhubarb, ...

Today marks 10 years since I developed ulcerative colitis.10 years.10 years.When I think about that, I feel a strange sensation.These past 10 years, I haven't been healthy the whole time.And even now, ...

Click here for the previous article↓ Nothing particularly eventful happened during my hospitalization. My usual attending physician came to check on me and said we would try a new medication after ...

Phase 3 ABTECT-Maintenance will report 44-week efficacy and safety of obefazimod in moderately to severely active UC using a randomized, double-blind, placebo-controlled design. Subset analyses will ...